A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2004
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004069149A3 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
11/25/2004	US20040236407 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
11/25/2004	US20040236153 Novel vasoconstrictor cannabinoid analogs
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235824 For the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235802 Combinations comprising cox-2-inhibitors and aspirin
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235737 A mixture of blood-coagulation factor IX and antihemophilic factor to treat hemophilia and blood disorders in patient not presenting with anti-FVIII antibodies
11/25/2004	US20040235727 Comprising H 376/95, sodium dodecyl sulphate, and a polymer selected from hydroxypropyl methylcellulose, hydroxyethyl cellulose, and polyoxyethylene oxide; use in treatment of thromboembolism
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004	US20040234572 Preparation of sustained release pharmaceutical composition
11/25/2004	CA2557615A1 Treatment of haemorrhagic shock using complement 5a receptor inhibitors
11/25/2004	CA2528220A1 Indazole-derivatives as factor xa inhibitors
11/25/2004	CA2526084A1 Azaindole-derivatives as factor xa inhibitors
11/25/2004	CA2526066A1 New indole derivatives as factor xa inhibitors
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525497A1 Peptides that bind to the erythropoietin receptor
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479680A1 Azaindole derivatives as Factor Xa inhibitors
11/24/2004	EP1479679A1 Triazole-derivatives as factor Xa inhibitors
11/24/2004	EP1479678A1 Pyrazole-derivatives as factor xa inhibitors
11/24/2004	EP1479677A1 New indole derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479675A1 Indazole-derivatives as factor Xa inhibitors
11/24/2004	EP1479674A1 Imidiazole-derivatives as factor xa inhibitors
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1479393A1 Stabilized albumin preparations
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478365A1 Combination consisting of trapidil and serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis
11/24/2004	EP1478362A1 A combination treatment for acute myocardial infarction
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1144673A4 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
11/24/2004	EP1098655B1 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
11/24/2004	EP1079805B1 Pharmaceutical composition comprising factor viii and neutral liposomes
11/24/2004	EP0946185B1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
11/24/2004	EP0826064B1 Low oxygen affinity mutant hemoglobin
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1548534A Reptilase and its production process and application
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548432A Stabilizing method and medicine composition of catechin monomer
11/24/2004	CN1548167A Hemostatic antibiotic products and preparnig method thereof
11/24/2004	CN1548153A Application of enzymic hemostat in antagonizing hirudin hemorrhage
11/24/2004	CN1548130A Medicine for treating coronary heart disease and angina pectoris and its pharmacologic effect
11/24/2004	CN1548119A Yiqingwan bolus and its prepn
11/24/2004	CN1548091A Leukocyte-increasing Radix astragali and donkey-hide gelatin Qijiao shengbai bolus and its prepn
11/24/2004	CN1548089A Blood-nourishing ass-hide gelatin bolus and its prepn
11/24/2004	CN1548079A Active part and effective component of Four Drug Decoction
11/24/2004	CN1548071A Blood nourishing tonic wine
11/24/2004	CN1548051A Tillering onion extract and its application
11/24/2004	CN1548036A Medicine containing acarnine compound as active component
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1176946C New-type alpha-interferon
11/24/2004	CN1176943C Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176719C Application for deplasmin in prepn. of internal hemostatic medicine
11/24/2004	CN1176713C Application of serum beta 2-glucoprotein I as active component of thrombolytics
11/24/2004	CN1176711C Dampness-removing embolism-dissolving medicinal liquor
11/24/2004	CN1176698C Process for preparing cerebral infarction sequal treating medicine
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	US6821968 Stable taurolidine electrolyte solutions
11/23/2004	US6821549 Contacting stent with a coating solution containing a coating material to be deposited on surface of stent; inserting thread through the lumen of the stent; producing relative motion between stent and thread to remove coating material
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor

1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 671